Management Team
The Prosensa Management Team:
-
Hans GCP Schikan - Chief Executive Officer
Hans GCP Schikan, Chief Executive Officer is responsible for the overall management and strategic direction of Prosensa.
-
Giles Campion - Chief Medical Officer & SVP R&D
Giles Campion, Chief Medical Officer and Senior Vice-President R&D is responsible for the company’s discovery and development strategy and activities.
-
Luc Dochez - Chief Business Officer & SVP Bus. Development
Luc Dochez, Chief Business Officer & SVP Business Development joined Prosensa in November 2008 and is responsible for all business and corporate development activities at the company.
-
Berndt Modig - Chief Financial Officer
Berndt Modig is responsible for the financial management and strategy of Prosensa. He has more than 20 years of international experience in finance and operations, private equity and M&A.
-
Judith van Deutekom - VP Drug Discovery
Judith van Deutekom, Vice-President Drug Discovery is a molecular biologist and has an extensive 17-year track record in the genetic research of muscular dystrophies.
-
Tina Flatau - VP Alliances and Project Management
Tina Flatau, VP Alliances and Project Management started working with Prosensa in 2009 and is responsible for management of Prosensa’s own development projects and collaboration programs.
-
Paul van Hagen - Director Finance & Control
Paul van Hagen, Director Finance & Control joined Prosensa in September 2011. He has more than 15 years of international experience in finance.
-
Richard H Holslag - VP Manufacturing
Richard H Holslag, VP Manufacturing joined Prosensa in February 2009 and is responsible for all Manufacturing activities.
-
Sjef de Kimpe - VP Early Drug Development
Sjef de Kimpe, Vice-President Early Drug Development is responsible for pre-clinical and early drug development.
